Aspiro Pharma Specialities Private Limited
About Aspiro Pharma Specialities Private Limited
Data last updated: 08 February 2026
Aspiro Pharma Specialities Private Limited was a private limited company based in Gujvail, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 29 August 2020.
Registered with ROC Hyderabad under CIN U24299TG2020PTC143320.
Capital: an authorised share capital of ₹55 Cr and a paid-up capital of ₹55 Cr. It was led by directors Bhavesh Bansidhar Pujara and Mahesh Ramappa Kamalamma Hassan.
Last AGM: 24 July 2025. Financial statements filed for year ended 31 March 2025. Office: 284 Biotech Park, Gujvail, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.9 Lakh, a decline of 46% compared to the previous year.
As per MCA filings, the company had open charges of ₹25 Cr and satisfied charges of ₹25 Cr on record.
The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressPlot No. S – 1 S – 6 & S – 2B Survey No. 321 & 284 Biotech Park Phase – Iii, Karakapatla Vill Markook Mandal Siddipet Dist, Gujvail, Telangana, India – 502281
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Auditor Details of Aspiro Pharma Specialities Private Limited
Aspiro Pharma Specialities Private Limited is audited by SREELATA AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SREELATA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Aspiro Pharma Specialities Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aspiro Pharma Specialities Private Limited
Aspiro Pharma Specialities Private Limited is currently managed by 2 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavesh Bansidhar Pujara | Director | 13 Nov 2024 | 1 Years 8 Months | As last reported |
|
Mahesh Ramappa Kamalamma Hassan
Also directs:
Aspiro Pharma Limited, Annora Pharma Private Limited
|
Director | 13 Nov 2024 | 1 Years 8 Months | As last reported |
Financials of Aspiro Pharma Specialities Private Limited FY 2025 filings available
Aspiro Pharma Specialities Private Limited reported revenue of ₹6.9 Lakh (down 46.00% YoY) for FY 2025.
Ten-year financial statements for Aspiro Pharma Specialities Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aspiro Pharma Specialities Private Limited
Shareholding and ownership data for Aspiro Pharma Specialities Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aspiro Pharma Specialities Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | State Bank of India | ₹25 Cr | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Aspiro Pharma Specialities Private Limited
Aspiro Pharma Specialities Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history for Aspiro Pharma Specialities Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Aspiro Pharma Specialities Private Limited
GST registrations and filing compliance for Aspiro Pharma Specialities Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Aspiro Pharma Specialities Private Limited
Credit ratings, litigation, and regulatory alerts for Aspiro Pharma Specialities Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aspiro Pharma Specialities Private Limited
MSME payment history for Aspiro Pharma Specialities Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aspiro Pharma Specialities Private Limited
Corporate group structure for Aspiro Pharma Specialities Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aspiro Pharma Specialities Private Limited
MCA filings and documents for Aspiro Pharma Specialities Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Aspiro Pharma Specialities Private Limited
Frequently Asked Questions about Aspiro Pharma Specialities Private Limited
Aspiro Pharma Specialities Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Aspiro Pharma Specialities Private Limited is a amalgamated private limited company in the pharma sector based in Gujvail, Telangana, India. It was incorporated on 29 August 2020 and is registered under CIN U24299TG2020PTC143320. The company was amalgamated as per MCA records and no longer exists as a legal entity.
Aspiro Pharma Specialities Private Limited was incorporated on 29 August 2020. Registered with ROC Hyderabad.
The current directors of Aspiro Pharma Specialities Private Limited are:
- Bhavesh Bansidhar Pujara - Director
- Mahesh Ramappa Kamalamma Hassan - Director
The CIN (Corporate Identification Number) of Aspiro Pharma Specialities Private Limited is U24299TG2020PTC143320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The primary industry of Aspiro Pharma Specialities Private Limited is pharma. The company specifically operates in drug formulation and development.